Less water means higher concentration
GLP-1 receptor agonists were originally developed to improve glycemic control
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest Statements Conflict of interest Within the last 36 months, FK has served on scientific advisory panels and/or been part of speaker's bureaus for, served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Gubra, MedImmune, MSD/Merck, Mundipharma, Norgine, Novo Nordisk, Sanofi and Zealand Pharma
The dose ranges on this peptide half-life chart are provided strictly for laboratory research and in-vitro reference purposes
If you have persistent GI intolerance, certain comorbidities, or you personally value a moderate weight change over maximal loss, a clinician might target a mid-range maintenance dose
Do not use this calculator to change your prescribed plan